In general, the pharmacokinetics of emtricitabine in infants, children and adolescents (aged 4 months up to 18 years) are similar to those seen in adults.
Üldiselt on emtritsitabiini farmakokineetika imikutel, lastel ja noorukitel (vanuses 4 kuud kuni 18 aastat) sarnane täiskasvanutel esinevaga.